HIGHLIGHTS
- who: July and colleagues from the Columbia University, United States have published the paper: Case Report: Pulmonary sarcomatoid carcinoma complicating TP53 mutation treated successfully with Tislelizumab combined with — a case report, in the Journal: (JOURNAL) of 23/06/2022
- what: The authors report for the first time the use of Tislelizumab in the treatment of advanced PSC, and the tumor retraction has reached almost complete remission.
SUMMARY
A laboratory examination revealed the following: White blood cell count 64.9 × 109/L, neutrophil absolute value 59.95 × 109/L, hemoglobin 57 g . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.